Is JetBlue The Best Airline Stock?
Following a general trend of improvement among airline stocks, shares…
Sell
44
FEMY Quote, Financials, Valuation and Earnings
Last price:
$0.87
Seasonality move
:
-26.75%
Day range:
$0.80 - $0.86
52-week range:
$0.31 - $1.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.81x
P/B ratio:
10.61x
Volume:
1.2M
Avg. volume:
6.9M
1-year change:
-27.49%
Market cap:
$48.3M
Revenue:
$1.6M
EPS (TTM):
-$0.72
Analysts' Opinion
-
Consensus RatingFemasys, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $5.17, Femasys, Inc. has an estimated upside of 525.05% from its current price of $0.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $0.83.
Fair Value
-
According to the consensus of 1 analyst, Femasys, Inc. has 525.05% upside to fair value with a price target of $5.17 per share.
FEMY vs. S&P 500
-
Over the past 5 trading days, Femasys, Inc. has underperformed the S&P 500 by -6.9% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Femasys, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Femasys, Inc. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Femasys, Inc. reported revenues of $729.4K.
Earnings Growth
-
Femasys, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Femasys, Inc. reported earnings per share of -$0.10.
Enterprise value:
52.2M
EV / Invested capital:
4.02x
Price / LTM sales:
11.81x
EV / EBIT:
--
EV / Revenue:
25.32x
PEG ratio (5yr expected):
-0.53x
EV / Free cash flow:
-2.59x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$438.5K
Return On Assets:
-138.71%
Net Income Margin (TTM):
-960.48%
Return On Equity:
-606.11%
Return On Invested Capital:
-180.14%
Operating Margin:
-500.93%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1M | $1.3M | $2.1M | $554.9K | $729.4K | |
| Gross Profit | -$172.7K | -$66K | $438.5K | $148.4K | $224.5K | |
| Operating Income | -$13.1M | -$17.5M | -$17.7M | -$5.1M | -$3.7M | |
| EBITDA | -$12.2M | -$16.6M | -$16.8M | -$4.9M | -$3.4M | |
| Diluted EPS | -$0.98 | -$0.82 | -$0.72 | -$0.24 | -$0.10 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $28.3M | $17.3M | $10.2M | $11.3M | $12.2M | |
| Total Assets | $31.2M | $20M | $14.9M | $15.6M | $16.3M | |
| Current Liabilities | $1.8M | $1.8M | $2.2M | $2.9M | $10.5M | |
| Total Liabilities | $2.5M | $2M | $4.4M | $9.6M | $11.7M | |
| Total Equity | $28.7M | $18M | $10.4M | $6M | $4.6M | |
| Total Debt | $1.2M | $782.5K | $2.9M | $6.7M | $7.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$11.1M | -$17.4M | -$19.6M | -$5.5M | -$5.4M | |
| Cash From Investing | -$192.9K | -$782K | -$544K | -$440K | -$239.8K | |
| Cash From Financing | $4M | $17.1M | $17.1M | -- | $7M | |
| Free Cash Flow | -$11.3M | -$18.2M | -$20.1M | -$5.9M | -$5.6M | |
FEMY
Sector
Market Cap
$48.3M
$28.5M
Price % of 52-Week High
45.92%
51.82%
Dividend Yield
0%
0%
Shareholder Yield
-104.66%
-1.4%
1-Year Price Total Return
-27.49%
-21.29%
Beta (5-Year)
--
0.519
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.89
200-day SMA
Sell
Level
$0.91
Bollinger Bands (100)
Buy
Level
0.45 - 0.89
Chaikin Money Flow
Buy
Level
189.3K
20-day SMA
Sell
Level
$0.88
Relative Strength Index (RSI14)
Sell
Level
49.07
ADX Line
Buy
Level
34.29
Williams %R
Neutral
Level
-65.6817
50-day SMA
Buy
Level
$0.75
MACD (12, 26)
Buy
Level
0.04
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
287.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-17.4284)
Sell
CA Score
(Annual)
Level (-4.3594)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (9.8205)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.
Stock Forecast FAQ
In the current month, FEMY has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FEMY average analyst price target in the past 3 months is $5.17.
-
Where Will Femasys, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Femasys, Inc. share price will rise to $5.17 per share over the next 12 months.
-
What Do Analysts Say About Femasys, Inc.?
Analysts are divided on their view about Femasys, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Femasys, Inc. is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is Femasys, Inc.'s Price Target?
The price target for Femasys, Inc. over the next 1-year time period is forecast to be $5.17 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FEMY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Femasys, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of FEMY?
You can purchase shares of Femasys, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Femasys, Inc. shares.
-
What Is The Femasys, Inc. Share Price Today?
Femasys, Inc. was last trading at $0.87 per share. This represents the most recent stock quote for Femasys, Inc.. Yesterday, Femasys, Inc. closed at $0.83 per share.
-
How To Buy Femasys, Inc. Stock Online?
In order to purchase Femasys, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get FEMY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FEMY
Sector
P/E ratio
--
23.52x
PEG ratio
-0.53x
-0.01x
P/B ratio
10.61x
1.82x
Price / LTM sales
11.81x
1.60x
Growth Metrics
FEMY
Sector
Revenue growth
31.44%
4.8%
Earnings growth
57.95%
11.11%
Revenue (5-year growth)
11.89%
6.45%
Earnings forecast
-$0.13
-$0.20
Profitability
FEMY
Sector
Profitability FY 2024
$212.2K
$3.5M
Return on invested capital
-180.14%
-31.16%
Return on assets
-138.71%
-27.72%
Return on equity
-606.11%
-37.13%
Earnings Date
Last Earnings Date
Nov
9
Next Earnings Date
Dec
11
Estimated Next Earnings Date
Mar
12
Balance Sheet
FEMY
Sector
Total cash
$4.6M
$27M
Short term investments
--
$25.7M
Total assets
$12.4M
$79.7M
Long term debt
$7.9M
$3.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Stock Ideas
Buy
64
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
50
PLAB alert for Dec 10
Photronics, Inc. [PLAB] is up 45.35% over the past day.
Buy
60
OLMA alert for Dec 10
Olema Pharmaceuticals, Inc. [OLMA] is up 15.35% over the past day.
Buy
84
TSAT alert for Dec 10
Telesat Corp. [TSAT] is up 3.07% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
